To investigate the apparent poor response to plozasiran, free glycerol was measured and GK genotyping performed, revealing that the patient carried a pathogenic loss-of-function variant in the GK gene (chrXp21.2) (Fig. 1) known to cause GKD (N288D variant) [7]. The gene discussed is GK; the disease is inborn glycerol kinase deficiency.